What are the benefits of using Xtinib Gefitinib 250mg Tablet?
In persons with certain types of malignancies, Xtinib Gefitinib 250mg Tablet is used to treat non-small cell lung cancer that has progressed to other regions of the body. Gefitinib belongs to the kinase inhibitor class of drugs.
What is the best way to take gefitinib?
Gefitinib should be taken once a day, with or without meals, as advised by your doctor. Place the tablet in a glass of water (4 to 8 ounces/120 to 240 milliliters) if you have problems swallowing it. 15 minutes of vigorous stirring Immediately consume the entire combination.
What are the side effects of Gefitinib?
- In the abdomen or stomach, there is tenderness or pain.
- Clay-based stools.
- reduced urge to eat
- diarrhea that is severe
- A rash or itching on the skin.
- a stomachache and a want to puke
- A common condition is swelling of the feet or lower legs.
- Yellow-tinged eyes or skin. For more details Click Here.
Is gefitinib crushable?
Xtinib Gefitinib 250mg Tablet pills are not crushable. You can dissolve the pill in half a glass of water if you can’t swallow it or if you’re using an NG tube to administer the medicine. Allow it to sit for a few moments. After that, combine everything and drink.
Gefitinib was created by who?
The FDA has approved AstraZeneca’s IRESSA® (gefitinib) as a first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) who had exon 19 deletions or exon 21 (L858R) substitution mutations in their tumors.
Why was gefitinib taken off the market?
Xtinib Gefitinib 250mg Tablet was on the market from 2003 to 2012, when it was withdrawn due to an inability to demonstrate clinical benefit in multiple randomized trials that did not restrict eligibility based on mechanism of action; that is, eligibility was not limited to patients with NSCLC who had a known EGFR “activating” mutation.
What is the purpose of gefitinib?
In persons with certain types of malignancies, gefitinib is used to treat non-small cell lung cancer that has progressed to other regions of the body. Gefitinib belongs to the kinase inhibitor class of drugs.